- Home
- HALO vs DCI Comparison
HALO vs DCI Comparison
Compare HALO & DCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HALO | DCI |
|---|---|---|
| Founded | 1998 | 1915 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Pollution Control Equipment |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.4B | 10.7B |
| IPO Year | N/A | 1987 |
Fundamental Metrics
Financial Performance| Metric | HALO | DCI |
|---|---|---|
| Price | $64.63 | $90.76 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 12 | 4 |
| Target Price | $73.33 | ★ $92.50 |
| AVG Volume (30 Days) | ★ 2.5M | 768.8K |
| Earning Date | 11-03-2025 | 12-04-2025 |
| Dividend Yield | N/A | ★ 1.30% |
| EPS Growth | ★ 56.68 | N/A |
| EPS | ★ 4.74 | 3.21 |
| Revenue | $1,242,852,000.00 | ★ $3,726,200,000.00 |
| Revenue This Year | $34.83 | $4.39 |
| Revenue Next Year | $24.84 | $4.49 |
| P/E Ratio | ★ $13.14 | $28.78 |
| Revenue Growth | ★ 31.19 | 2.37 |
| 52 Week Low | $46.26 | $57.45 |
| 52 Week High | $79.50 | $95.00 |
Technical Indicators
Market Signals| Indicator | HALO | DCI |
|---|---|---|
| Relative Strength Index (RSI) | 44.64 | 55.85 |
| Support Level | $61.23 | $91.91 |
| Resistance Level | $63.26 | $93.40 |
| Average True Range (ATR) | 2.25 | 1.95 |
| MACD | -0.34 | -0.02 |
| Stochastic Oscillator | 26.22 | 52.00 |
Price Performance
Historical ComparisonAbout HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.
About DCI Donaldson Company Inc.
Donaldson is a leading manufacturer of filtration systems and replacement parts (including air filtration systems, liquid filtration systems, and dust, fume, and mist collectors). The company serves a diverse range of end markets, including construction, mining, agriculture, truck, and industrial. Its business is organized into three segments: mobile solutions, industrial solutions, and life sciences. Donaldson generated approximately $3.7 billion in revenue in its fiscal 2025.